The purpose of this national diagnosis and treatment protocol (PNDS) is to outline to health providers the optimum management and integrated care pathway for patients with long-term conditions (ALD), particularly with status ALD 11: xeroderma pigmentosum (XP).
See also
HAS opinions and decisions
17/06/2009
eNq1mF1v2jAUhu/5FVHuSYDxOQWqjbUbUqsxCtq0G2SSEzALdnpsA92vn0OoBlPSrqa+jO2858Tn9eOjBFf7TeJsAQXlrO/WvZrrAAt5RNmy786mN9WuezWoBGuyJSfLOl7NqzdcJ0yIEH03m/UWQJjwftzdfgL9PqA7qDgBX6whlGfrlKSJ94WI1R1JszVOsOU0cjYgVzzqu6mSh1EnEBJ1FoMdx18iJSEE/nHkdHY9b56OB34m9h+qSgDeErYsFAVmpBkqRGBySCQsOT4WSqcY1eeNXrfXbnaMglAxAcEVhjAmcjVGvqURRIWxYpIIMAoS76J7wG0CMgtSKO6vw40wEidrsp/Aw6g46Q96dij3slqr1jvdWrtRb/WarWbNKBSebFWxffRH+OG81Wr3ujUfmL8HzMy7IdWULje6mlyojWGhxhwlSSyViIrhud0sxUF4eNEKERVpQh69tUhNt4og0dOAGgr2PiT7gilqTCV6z/7RZypJ/FdmPTtCxFLGGaOGXDFZwpKbielGDDmTsC+vqBn+5P7oRQri7WR/c1aM/rFaJDQ05ZsmkAIhZ5NROd6skeEjETBDe2j4TlnEd+LtkXNaYkvZpwdqPnt5tuutlvGJ+qn9VHL3XCvkKfgaRlRcwpgRi/mldNEWLZZ6Mqgdbx76Ih6SBEo6o6ohdbQpnxo5a7a3d6TyiULRz9dTU698U4CP94fHQmka9Z+qbEZkG5jXxizN+/U2z0/7sy1zHM4b3c67Ts9sExQWw2QlZSre+/5ut/NWRFQF0ZvlxWiX/Cc3r73e3cr1nrc7OT0tpb7Ir8XXlcv08L3UAFza1B7fPzbPhTEkKrigFjmnrdF0dP32gP7b0VpLe3xGFHthDt0nkZQzW42QWhQqXnQl6LKyG9R8+BrHtOSfSqktAz//nzOoBH72L2dQ+QPpl/6X
EW320ZBRKYwfGb40
